Li Hailan, Luo Shiyong, Zhang Youming, Xiao Xiaoyi, Liu Huaping
Department of Radiology, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, 410000, Hunan Province, People's Republic of China.
Department of Radiology, Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, 430060, Hubei Province, People's Republic of China.
J Inflamm Res. 2021 Mar 25;14:1111-1124. doi: 10.2147/JIR.S303773. eCollection 2021.
To evaluate longitudinal computed tomography (CT) features and the predictive value of the initial CT and clinical characteristics for mortality in patients with severe/critical coronavirus disease 2019 (COVID-19) pneumonia.
A retrospective analysis was performed on patients with COVID-19 pneumonia confirmed by laboratory. By excluding mild and common patients, 155 severe/critical patients with definite outcome were finally enrolled. A total of 516 CTs of 147 patients were divided into four stages according to the time after onset (stage 1, 1-7 days; stage 2, 8-14 days; stage 3, 15-21 days, and stage 4, >21 days). The evolving imaging features between the survival and non-survival groups were compared by using Chi-square, Fisher's exact test, student's -test or Mann-Whitney -test, as appropriate. The predictive value of clinical and CT features at admission for mortality was analysed through logistic regression analysis. To avoid overfitting caused by CT scores, CT scores were divided into two parts, which were combined with clinical variables, respectively, to construct the models.
Ground-glass opacities (GGO) patterns were predominant for stages 1 and 2 for both groups (both >0.05). The numbers of consolidation lesions increased in stage 3 in both groups (=0.857), whereas the linear opacity increased in the survival group but decreased in the non-survival group (=0.0049). In stage 4, the survival group predominantly presented linear opacity patterns, whereas the non-survival group mainly showed consolidation patterns (=0.007). Clinical and imaging characteristics correlated with mortality; multivariate analyses revealed age >71 years, neutrophil count >6.38 × 10/L, aspartate aminotransferase (AST) >58 IU/L, and CT score (total lesions score >17 in model 1, GGO score >14 and consolidation score >2 in model 2) as independent risk factors (all <0.05). The areas under the curve of the six independent risk factors alone ranged from 0.65 to 0.75 and were 0.87 for model 2, 0.89 for model 1, and 0.92 for the six variables combined. Statistical differences were observed between Kaplan Meier curves of groups separated by cut-off values of these six variables (all <0.01).
Longitudinal imaging features demonstrated differences between the two groups, which may help determine the patient's prognosis. The initial CT score combined with age, AST, and neutrophil count is an excellent predictor for mortality in COVID-19 patients.
评估2019冠状病毒病(COVID-19)重症/危重症肺炎患者的纵向计算机断层扫描(CT)特征以及初始CT和临床特征对死亡率的预测价值。
对实验室确诊的COVID-19肺炎患者进行回顾性分析。排除轻症和普通患者后,最终纳入155例结局明确的重症/危重症患者。将147例患者的516次CT扫描根据发病后的时间分为四个阶段(阶段1,1 - 7天;阶段2,8 - 14天;阶段3,15 - 21天;阶段4,>21天)。根据情况,采用卡方检验、Fisher精确检验、学生t检验或Mann-Whitney U检验比较生存组和非生存组之间不断演变的影像学特征。通过逻辑回归分析评估入院时临床和CT特征对死亡率的预测价值。为避免CT评分导致的过度拟合,将CT评分分为两部分,分别与临床变量相结合构建模型。
两组在阶段1和阶段2磨玻璃影(GGO)模式均占主导(均>0.05)。两组在阶段3实变病灶数量均增加(P = 0.857),而生存组的条索状影增加,非生存组减少(P = 0.0049)。在阶段4,生存组主要表现为条索状影模式,而非生存组主要表现为实变模式(P = 0.007)。临床和影像学特征与死亡率相关;多因素分析显示年龄>71岁、中性粒细胞计数>6.38×10⁹/L、天冬氨酸转氨酶(AST)>58 IU/L以及CT评分(模型1中总病灶评分>17,模型2中GGO评分>14且实变评分>2)为独立危险因素(均P<0.05)。单独的六个独立危险因素的曲线下面积范围为0.65至0.75,模型2为0.87,模型1为0.89,六个变量联合为0.92。在根据这六个变量的截断值分组的Kaplan Meier曲线之间观察到统计学差异(均P<0.01)。
纵向影像学特征显示两组之间存在差异,这可能有助于判断患者的预后。初始CT评分结合年龄、AST和中性粒细胞计数是COVID-19患者死亡率的良好预测指标。